APUS APIMEDS PHARMACEUTICALS US I
FollowCOM SHS (common), issuer CIK 1894525
6 managers (7 13F filers) reported a position in APUS shares at 2026-06-30, 426,282 shares in all. 2 filers opened a position and 1 filer sold out during the quarter.
- Managers
- 6
- 13F filers
- 7
- New
- 2
- Added
- 1
- Reduced
- 2
- Sold out
- 1
- Shares held by filers
- 426,282
Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
No Form 4 transaction on this security in the data.
13F holders, Q2 2026
Filers in the available 13F reports with a share position at 2026-06-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| Hemenway Trust Co LLC | 274,000 | $247K | 0.02% | 0 | 13F-HRTimeline |
| VANGUARD GROUP INCgroup of 2 filers holding | 87,693 | $78.9K | -32,275 | Timeline
| |
| GEODE CAPITAL MANAGEMENT, LLCin group GEODE CAPITAL MANAGEMENT, LLC | 35,114 | $31.6K | <0.01% | -4,937 | 13F-HRTimelineGroup |
| JANE STREET GROUP, LLCin group JANE STREET GROUP, LLC | 15,993 | $14.4K | <0.01% | new | 13F-HRTimelineGroup |
| UBS Group AGin group UBS Group AG | 11,818 | $10.6K | <0.01% | +7,631 | 13F-HRTimelineGroup |
| Tower Research Capital LLC (TRC)in group Tower Research Capital LLC (T… | 1,664 | $1.5K | <0.01% | new | 13F-HRTimelineGroup |